Filana Therapeutics, Inc.
MX ˙ BMV ˙ US14817C1071
SecurityMX:FLNA / Filana Therapeutics, Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership596,242 shares
Latest Disclosed Value $ 1,008,020
Geode Capital Management, Llc reports 9.21% increase in ownership of FLNA / Filana Therapeutics, Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 596,242 shares of Filana Therapeutics, Inc. (MX:FLNA) valued at $1,008,020 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 545,969 shares of Filana Therapeutics, Inc.. This represents a change in shares of 9.21% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F FILANA THERAPEUTICS COM 14817C107 596,242 50,273 9.21 1,008 -6.75 0.0000
2026-02-09 2025-12-31 13F CASSAVA SCIENCES COM 14817C107 545,969 8,068 1.50 1,081 -30.93 0.0001
2025-11-12 2025-09-30 13F CASSAVA SCIENCES COM 14817C107 537,901 15,022 2.87 1,566 65.43 0.0001
2025-08-08 2025-06-30 13F CASSAVA SCIENCES COM 14817C107 522,879 -503,720 -49.07 947 -38.57 0.0001
2025-05-13 2025-03-31 13F CASSAVA SCIENCES COM 14817C107 1,026,599 19,604 1.95 1,540 -35.21 0.0001
2025-02-12 2024-12-31 13F CASSAVA SCIENCES COM 14817C107 1,006,995 -1,598 -0.16 2,377 -91.99 0.0002
2024-11-12 2024-09-30 13F CASSAVA SCIENCES COM 14817C107 1,008,593 41,289 4.27 29,688 148.48 0.0024
2024-08-09 2024-06-30 13F CASSAVA SCIENCES COM 14817C107 967,304 65,464 7.26 11,949 -34.71 0.0010
2024-05-13 2024-03-31 13F CASSAVA SCIENCES COM 14817C107 901,840 27,844 3.19 18,301 -6.99 0.0017
2024-02-13 2023-12-31 13F CASSAVA SCIENCES COM 14817C107 873,996 43,746 5.27 19,676 42.40 0.0021
2023-11-13 2023-09-30 13F CASSAVA SCIENCES COM 14817C107 830,250 26,944 3.35 13,817 -29.85 0.0016
2023-08-11 2023-06-30 13F CASSAVA SCIENCES COM 14817C107 803,306 44,350 5.84 19,697 7.60 0.0023
2023-05-15 2023-03-31 13F CASSAVA SCIENCES COM 14817C107 758,956 50,164 7.08 18,306 91,430.00 0.0024
2023-02-13 2022-12-31 13F CASSAVA SCIENCES COM 14817C107 708,792 23,941 3.50 21 -99.93 0.0029
2022-11-14 2022-09-30 13F CASSAVA SCIENCES COM 14817C107 684,851 11,309 1.68 28,640 51.21 0.0043
2022-08-12 2022-06-30 13F CASSAVA SCIENCES COM 14817C107 673,542 27,695 4.29 18,940 -21.04 0.0028
2022-05-13 2022-03-31 13F CASSAVA SCIENCES COM 14817C107 645,847 9,423 1.48 23,986 -13.75 0.0030
2022-02-11 2021-12-31 13F CASSAVA SCIENCES COM 14817C107 636,424 -2,049 -0.32 27,811 -29.83 0.0033
2021-11-12 2021-09-30 13F CASSAVA SCIENCES COM 14817C107 638,473 6,292 1.00 39,636 -26.62 0.0053
2021-08-13 2021-06-30 13F CASSAVA SCIENCES COM 14817C107 632,181 70,504 12.55 54,013 113.94 0.0074
2021-05-12 2021-03-31 13F CASSAVA SCIENCES COM 14817C107 561,677 103,857 22.69 25,247 708.68 0.0039
2021-02-12 2020-12-31 13F CASSAVA SCIENCES COM 14817C107 457,820 152,233 49.82 3,122 -11.23 0.0005
2020-11-13 2020-09-30 13F CASSAVA SCIENCES COM 14817C107 305,587 45,008 17.27 3,517 338.53 0.0007
2020-08-13 2020-06-30 13F CASSAVA SCIENCES COM 14817C107 260,579 149,082 133.71 802 75.11 0.0002
2020-05-14 2020-03-31 13F CASSAVA SCIENCES COM 14817C107 111,497 -32,754 -22.71 458 -38.93 0.0001
2020-02-20 2019-12-31 13F/A-1 CASSAVA SCIENCES COM 14817C107 144,251 69,519 93.02 750 742.70 0.0002
2020-02-13 2019-12-31 13F CASSAVA SCIENCES COM 14817C107 144,251 69,519 750 95.5809
2019-11-12 2019-09-30 13F CASSAVA SCIENCES COM 14817C107 74,732 0 0.00 89 -1.11 0.0000
2019-08-14 2019-06-30 13F CASSAVA SCIENCES COM 14817C107 74,732 8,664 13.11 90 5.88 0.0000
2019-05-14 2019-03-31 13F CASSAVA SCIENCES COM 14817C107 66,068 66,068 85 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.